Home Furnishings

Keeson

Keeson released FY2026 Q1 earnings on April 27 After-Market (BJT), actual revenue CNY 868.19 M, actual EPS CNY 0.1

Keeson to Release FY2026 Q1 Earnings Report on April 28 After-Market BJT

Keeson released FY2025 annual earnings on April 17 After-Market (BJT), actual revenue CNY 3.03 B (forecast CNY 3.108 B), actual EPS CNY 0.29 (forecast CNY 0.56)

Keeson released FY2025 Q4 earnings on April 17 After-Market (BJT), actual revenue CNY 805.93 M, actual EPS CNY -0.1058

Keeson to Release FY2025 Earnings on April 18 After-Market (BJT), Forecast Revenue CNY 3.108 B, EPS CNY 0.56

Keeson released FY2025 9 Months earnings on October 24 Pre-Market (BJT), actual revenue CNY 2.224 B, actual EPS CNY 0.4185

Keeson released FY2025 Q3 earnings on October 24 Pre-Market (BJT), actual revenue CNY 764.43 M, actual EPS CNY 0.1196

Keeson to Release FY2025 Q3 Earnings on October 25, Pre-Market BJT

Keeson released FY2025 Q2 earnings on August 22 Pre-Market (BJT), actual revenue CNY 672.78 M, actual EPS CNY 0.1688

Keeson released FY2025 Semi-Annual earnings on August 22 Pre-Market (BJT), actual revenue CNY 1.459 B, actual EPS CNY 0.3

Keeson to Release FY2025 Semi-Annual Earnings on August 23, 2025 (BJT)

Qikeng Technology Receives BB ESG Rating from Huazheng Index

Qi Sheng Technology Listed as Brain-Computer Interface Concept Stock and Facing Accounts Receivable Issues

Qikeng Technology Announces 2024 Annual Report and 1Q2025 Earnings

QiSheng Technology's stock price abnormally fluctuates with consecutive limit-up

Q1 2025 Kyson Tech Net Profit Declines

Keeson released FY2025 Q1 earnings on April 28 After-Market BJT, actual revenue CNY 786.62 M, actual EPS CNY 0.13

Keeson FY2025 Q1 Earnings Release Scheduled for April 29, After-Market BJT

Qikeng Technology Announces 2024 Financial Report, Plans to Distribute 1 Yuan Cash Dividend per 10 Shares

Keeson released FY2024 annual earnings on April 18 After-Market (BJT), actual revenue CNY 2.958 B (forecast CNY 3.14 B), actual EPS CNY 0.44 (forecast CNY 0.5)

Ordinary dividend (cash)

Ex Date: 2026.05.26, Cash dividend 0.14 CNY

300007

603610

301330

300976

300801

603579

With the adjustment of the brain-computer interface concept, Rongtai health hit the limit down, and Taihe Technologies, Hanwei Electronics, Keeson, ZKTECO, Tarry, and others followed suit

Zhitong

Hanwei Electronics

ZKTECO

Tarry

Taihe Technologies

Rongtai health

Concept adjustment of brain-computer interface, Rongtai health hits the limit down

According to the Zhitong Finance APP, Keeson disclosed its third-quarter report for 2025. The company achieved revenue of 2.224 billion yuan in the first three quarters, a year-on-year increase of 0.08%; net profit attributable to the parent company was 147 million yuan, a year-on-year decrease of 2.74%; net profit excluding non-recurring gains and losses was 149 million yuan, a year-on-year decrease of 11.89%; basic earnings per share were 0.42 yuan

Keeson Technology released its performance for the first three quarters, with a net profit attributable to the parent company of 147 million yuan, a year-on-year decrease of 2.74%

Keeson announced that its controlling shareholder Jiaxing Zhihai Investment Management Co., Ltd., Chairman Tang Guohai, and Deputy General Manager Chen Genlei plan to reduce their holdings by no more than 3.09% of the company's shares

Keeson: Shareholders plan to reduce their holdings by no more than 3.09% of the company's shares

Keeson, under its subsidiary Mai Dong Shu Kang, has launched the country's first personalized sleep digital therapy product - the XBT-I Short-term Insomnia Digital Therapy Comprehensive Management System. This product combines brain-computer interface and AI large model technology, aiming to meet the sleep needs of segmented populations. The company is expanding the digital sleep industry chain through fund-controlled investments, successfully developing multiple sleep service products and obtaining a Class II medical device registration certificate

Keeson: Its subsidiary, Mai Dong Shu Kang, has launched the first personalized digital therapy for sleep in China

301336

China Galaxy Securities released a research report indicating that the healthy sleep market is rapidly expanding, with AI smart mattresses as the core category, having a low penetration rate but broad prospects. It is expected that by 2027, the market size will reach 658.68 billion yuan, with a compound annual growth rate of 8.5%. The demand for smart mattresses has increased from 93,000 units in 2015 to 1.495 million units in 2023, with a compound annual growth rate of 40.2%. With technological advancements and increasing consumer demand, the penetration rate of the smart mattress market is expected to rise rapidly, with the market size projected to approach 60 billion yuan by 2030

Qushui

China Galaxy Securities: Technological Progress + Leading Layout AI Smart Mattress Riding the Wind of Prosperity

According to the Zhitong Finance APP, Keeson Technology released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 1.459 billion yuan, a year-on-year increase of 0.07%. The net profit attributable to shareholders of the listed company was 106 million yuan, a year-on-year increase of 24.18%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 112 million yuan, a year-on-year decrease of 8.04%. The basic earnings per share were 0.3 yuan

Keeson Technology released its performance for the first half of the year, with a net profit attributable to the parent company of 106 million yuan, a year-on-year increase of 24.18%

688626

002173

688580

301293

300430

The concept of brain-computer interfaces has seen a surge, with Keeson hitting the daily limit up, followed by increases in VISHEE, Sanbo, CTN, Xiangyu Medical, and Innovative Medical

Xiangyu Medical

Innovative Medical

VISHEE

Sanbo

Keeson Technology Co., Ltd. has completed the industrial and commercial change registration and obtained a new business license. This change includes adjustments to the registered capital, registered address, and business scope, with a registered capital of 352,991,621 yuan, a registered address at No. 1508, Xiushui Avenue, Wangjiangjing Town, Xiuzhou District, Jiaxing City, Zhejiang Province, and a business scope covering intelligent equipment manufacturing, medical device production, and goods import and export, among others

Keeson: Completed the industrial and commercial change registration and obtained a new business license

300753

300016

The concept of brain engineering has seen an expanded increase, with the sector rising nearly 6%. BeiLu Pharma, APON, Keeson, Nanjing Panda, Innovative Medical, and others have hit the daily limit. On the news front, US stocks in brain regeneration technology surged 283% on June 16

APON

Beilu Pharma

Regencell Bioscience

The concept of brain engineering has seen an expanded increase, with multiple stocks hitting the daily limit

Keeson announced on May 9, 2025, that the company's production and operations are normal, and there are no significant matters that should be disclosed but have not been disclosed. From May 6 to May 9, 2025, the company's stock hit the daily limit for four consecutive trading days, with a closing price of 15.04 yuan, an increase of 10.02%. According to relevant regulations, the abnormal fluctuations in stock trading have been confirmed

Keeson Technology, which has seen four consecutive trading limits, stated that its production and operations are currently normal, and there are no significant matters that should be disclosed but have not been disclosed

Keeson(603610.SH)